Drug ID: | NPD7459 |
Drug Name: | Brostallicin |
Molecular Formula: | C30H35BrN12O5 |
Canonical SMILES: | NC(=N)NCCNC(=O)c1cc(cn1C)NC(=O)c1cc(cn1C)NC(=O)c1cc(cn1C)NC(=O)c1cc(cn1C)N=C(C(=C)Br)O |
Standard InCHI: | InChI=1S/C30H35BrN12O5/c1-16(31)25(44)36-17-9-22(41(3)12-17)27(46)38-19-11-24(43(5)14-19)29(48)39-20-10-23(42(4)15-20)28(47)37-18-8-21(40(2)13-18)26(45)34-6-7-35-30(32)33/h8-15H,1,6-7H2,2-5H3,(H,34,45)(H,36,44)(H,37,47)(H,38,46)(H,39,48)(H4,32,33,35) |
Standard InCHIKey: | RXOVOXFAAGIKDQ-UHFFFAOYSA-N |
Max Developmental Stage: | Phase 2 |
Max Developmental Stage Source: | ChEMBL |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL002299 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 6918408 |
ChEBI | |
CAS Number |
Molecular Weight | 722.20 |
ALogP | -1.4449 |
MLogP | 2.78 |
XLogP | 0.997 |
HDA | 17 |
HBD | 8 |
Rotatable Bonds | 24 |
TPSA | 230.61 |
RO5 Violation | 3 |